Default company panoramic image

Company Summary

Fetch Pharma is a life science company developing homologues of human biotech drugs for America's 75 million pet dogs. Biologics are among the top-selling drugs for humans yet there are no marketed canine-specific biologics. Fetch intends to change that by developing a portfolio of products for intractable canine diseases such as cancer, anemia and arthritis. The company expects to be cash flow positive in 5 years based on sales of 2 products.

Team

  • Default avatar
    Karen Auditore-Hargreaves
    CEO

  • Default avatar
    Phil Bergman
    Chief Medical Officer (consulting)

  • Default avatar
    Grant Risdon
    COO

    contact: [email protected]

Advisors

  • Default avatar
    Russ Weed, Graham & Dunn
    Lawyer
    Unconfirmed